home / stock / supn / supn short
Short Information | Supernus Pharmaceuticals Inc. (NASDAQ:SUPN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,322,872 |
Total Actual Volume | 9,364,289 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 66,144 |
Average Short Percentage | 13.97% |
Is there a SUPN Short Squeeze or Breakout about to happen?
See the SUPN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-16-2024 | $28.41 | $29.16 | $29.645 | $28 | 1,090,007 | 57,497 | 5.27% |
05-15-2024 | $29.2 | $28.74 | $29.565 | $28.65 | 381,638 | 43,372 | 11.36% |
05-14-2024 | $29.81 | $28.97 | $30.19 | $28.86 | 557,388 | 45,284 | 8.12% |
05-13-2024 | $29.14 | $29.68 | $30.32 | $29.14 | 549,388 | 91,190 | 16.6% |
05-10-2024 | $30.34 | $28.96 | $30.57 | $28.27 | 922,410 | 181,341 | 19.66% |
05-09-2024 | $31.52 | $30 | $32.87 | $29.04 | 1,066,039 | 212,377 | 19.92% |
05-08-2024 | $30.97 | $31.3 | $31.56 | $30.76 | 461,434 | 84,468 | 18.31% |
05-07-2024 | $30.56 | $31.15 | $31.31 | $30.41 | 471,705 | 80,197 | 17% |
05-06-2024 | $31.04 | $30.42 | $31.405 | $30.14 | 335,111 | 60,574 | 18.08% |
05-03-2024 | $30.74 | $30.83 | $30.91 | $30 | 362,427 | 40,668 | 11.22% |
05-02-2024 | $30.53 | $30.27 | $30.66 | $29.79 | 319,381 | 54,198 | 16.97% |
05-01-2024 | $30.15 | $30.08 | $30.69 | $29.99 | 394,210 | 42,812 | 10.86% |
04-30-2024 | $30.4 | $30.1 | $30.7 | $30.03 | 288,562 | 25,972 | 9% |
04-29-2024 | $30.35 | $30.6 | $31.27 | $30.35 | 365,488 | 64,293 | 17.59% |
04-26-2024 | $29.46 | $30.07 | $30.19 | $29.17 | 330,640 | 37,076 | 11.21% |
04-25-2024 | $30.03 | $29.31 | $30.22 | $29.17 | 351,464 | 31,649 | 9% |
04-24-2024 | $29.96 | $30.26 | $30.395 | $29.82 | 201,715 | 32,162 | 15.94% |
04-23-2024 | $29.75 | $29.95 | $31.84 | $29.59 | 201,175 | 22,258 | 11.06% |
04-22-2024 | $29.56 | $29.71 | $30.3 | $29.28 | 352,474 | 45,184 | 12.82% |
04-19-2024 | $28.67 | $29.4 | $29.53 | $28.67 | 361,633 | 70,300 | 19.44% |
News, Short Squeeze, Breakout and More Instantly...
Supernus Pharmaceuticals Inc. Company Name:
SUPN Stock Symbol:
NASDAQ Market:
Supernus Pharmaceuticals Inc. Website:
ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing...
ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company will hold a webcast and confe...
Net sales of Qelbree ® increased 75% to $45.1 million compared to first quarter 2023. Total revenues were $143.6 million. Total revenues excluding Trokendi XR ® and Oxtellar XR ® net product sales (non-GAAP) (1) increased 12% to $100.7 million compared to first ...